Vinay Prasad leaves FDA after less than three months amid Duchenne gene therapy controversy

A senior official at the US Food and Drug Administration has suddenly resigned after only three months in the job. Vinay Prasad’s departure followed controversy over a treatment for Duchenne muscular dystrophy.